Compounded Tirzepatide

Once-weekly injectable

Dual GIP and GLP-1 agonist

A dual-action therapy targeting both GIP and GLP-1 receptors. In published trials this class produced greater average weight reduction than GLP-1 therapy alone.

From $249/mo

Prescription treatment. Prescribed only when clinically appropriate, after review by a licensed provider.

Start your online visit How it works →

Provider reviewedUS-licensed pharmacyFree discreet shipping

What to expect

Why patients choose compounded tirzepatide

✓

Dual receptor action on both GIP and GLP-1 pathways

✓

Greater average reduction than single-agonist therapy in trials

✓

Strong effect on glucose control

✓

Once-weekly injection

How it works

The mechanism

Tirzepatide activates two incretin receptors rather than one. GIP appears to improve how fat is stored and used while GLP-1 governs appetite and gastric emptying, and the combination produces a larger metabolic effect for many patients.

Individual results vary.

Dosing

How it is taken

Begins at 2.5 mg weekly with increases roughly every four weeks as tolerated. Titration is slower for patients sensitive to gastrointestinal effects.

Safety information

What you should know before starting

Possible side effects

Nausea, particularly after dose increases
Diarrhoea, constipation or reflux
Reduced appetite to the point of under-eating if not monitored
Rare but serious: pancreatitis, gallbladder disease

Not suitable for

Personal or family history of medullary thyroid carcinoma
Multiple Endocrine Neoplasia syndrome type 2
Pregnancy, planning pregnancy, or breastfeeding
History of pancreatitis

Prescription treatment. Prescribed only when clinically appropriate, after review by a licensed provider. This is not a complete list of risks. Your provider will review your full medical history before prescribing.

Questions

Frequently asked

Semaglutide targets GLP-1 only. Tirzepatide targets GIP as well, and average weight reduction in trials has been higher. It also tends to cost more.

Not always. Many providers begin with semaglutide and move to tirzepatide if results plateau or tolerance allows. Your provider will recommend based on your history and goals.

Yes. Store vials in the refrigerator and keep them out of direct light. Full storage instructions ship with your order.

Related treatments